India requires a total of 6.6 crore doses of coronavirus vaccines to vaccinate healthcare and frontline workers and has secured sufficient quantities, a top government official said on Wednesday.
Niti Aayog Member V.K. Paul said, "6.6 crores doses of vaccines are required for healthcare and frontline workers (HCWs/FLWs). Sixty million (six crores) doses along with some buffer stock. Sufficient quantities of vaccine and logistics have been secured for HCWs and FLWs.”
Two vaccines - Oxford-AstraZeneca's Covishield manufactured by Serum Institute of India and Bharat Biotech's Covaxin have been approved for restricted emergency use on Sunday by the drug regulator. The vaccines will be first given to one crore healthcare workers and two crore frontline workers for free. Both these vaccines are of a two-dose shot.
"All preparations are on-track to roll-out the vaccination. It is possible to go into implementations reasonably soon, in coming days," Paul said.
On Tuesday, the Health Ministry announced that the vaccination drive will be rolled out from January 13 once they receive the vaccine.
Expanding more on the government's decisions, he said that sufficient quantities of syringes and other logistics have already been provided to the states and Union Territories for the next six months and beyond.
Besides these three crore health care and front line workers, 26 crore people above the age of 50 and one crores below the age of 50, with co-morbidities, will be vaccinated.
Paul added, "We believe that we would have enough stockpile to cater to this in about 7-8 months.”
Also Read: Biennial Legislative Council elections in UP, AP on January 28
Explaining why 26 crore people above the age of 50 were chosen for the priority vaccination, he said: "78 per cent of deaths among Covid-19 cases in India occurs over the age of 50 years. About 67 per cent of those who die have serious co-morbidities, like renal condition, diabetes, heart condition."
"People above the age of 50 emerge as distinct potential priority group because you capture mortality and co-morbidities. That is what led the National Expert Group on Vaccine Administration for Covid-19 (NEGVAC) to propose this priority group," he said.